In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand

Wiener Klinische Wochenschrift, Supplement

Volumn 116, Issue 4 SUPPL., 2004, Pages 41-46

  Pilz, Julia Beatrice ^a   Wernsdorfer, Gunther ^b   Sirichaisinthop, Jeeraphat ^c   Rojanawatsirivet, Chaiporn ^c   Wiedermann, Gerhard ^d   Wernsdorfer, Walther H ^b,d,e  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Div Specific Prophylaxis/Trop Med   (Austria)

Author keywords

Drug sensitivity; Lumefantrine; Malaria; Plasmodium falciparum; Thailand

Indexed keywords

ARTEMETHER; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE;

ANTIBIOTIC SENSITIVITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG STRUCTURE; GEOGRAPHIC DISTRIBUTION; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; STATISTICAL ANALYSIS; THAILAND;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MEFLOQUINE; PLASMODIUM FALCIPARUM; SESQUITERPENES; THAILAND;

EID: 11244309898     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Wernsdorfer G, Wernsdorfer WH (2003) Malaria at the turn of the 2nd to the 3rd millennium. Wien Klin Wochenschrift 115 [Suppl 3]: 2-9
2. World Health Organization (2000) WHO Expert Committee on Malaria. Twentieth Report. WHO Technical Report Series no 892. WHO, Geneva
3. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR (2002) Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209-218
4. Wernsdorfer WH, Chongsuphajaisiddhi T, Salazar NP (1994) A symposium on containment of mefloquine-resistant falciparum malaria in Southeast Asia, with special reference to border malaria. Southeast Asian J Trop Med Publ Health 25: 11-18
5. World Health Organization (2001) The use of antimalarial drugs. WHO document WHO/CDS/RBM/2001.33. WHO, Geneva
6. World Health Organization (1990) Practical chemotherapy of malaria. Report of a WHO Scientific Group. WHO Technical Report Series no 805, pp 124-126
7. Wernsdorfer WH, Landgraf B, Kilimali VA, Wernsdorfer G (1998) Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Tropica 70: 9-15
8. Alin H, Bjorkman A, Wernsdorfer WH (1999) Synergism of beflumetol and artemether in Plasmodium falciparum. Am J Trop Med Hyg 61: 439-445
9. Wernsdorfer WH (2004) Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Rev Anti-infect Ther 2: 89-104
10. Wernsdorfer WH, Payne D (1988) Drug sensitivity tests in malaria parasites. In Wernsdorfer WH, McGregor IA (eds) Malaria. Principles and practice of malariology. Churchill Livingstone, Edinburgh, pp 1765-1800
11. World Health Organization (1991) Basic malaria microscopy, part I. WHO, Geneva
12. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharm Exp Ther 96: 99-113
13. Wernsdorfer WH, Wernsdorfer MG (1995) The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitt Österr Ges Trop Med Parasit 17: 221-228
14. Wernsdorfer WH, Landgraf B, Kilimali VAEB, Wernsdorfer G (1998) Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Tropica 70: 9-15
15. Noedl H, Allmendinger T, Prajakwong S, Wernsdorfer G, Wernsdorfer WH (2001) Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother 45: 2106-2109
16. Noedl H (1997) In vitro Sensibilität thailändischer Isolate von Plasmodium falciparum gegenüber Benflumetol, TA2256, Chinin und Chinidin. Dissertation, Universität Wien
17. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F (2000) Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 94: 537-544
18. Na-Bangchang K, Karbwang J, Tasanor U, Thanavibul A, Farkad E, Mull R (1999) Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria. Int J Clin Pharm Res 19: 41-46
19. Tanariya P, Tippawangkoso P, Karbwang J, Na-Bangchang K, Wernsdorfer WH (2000) In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether. Br J Clin Pharmacol 49: 437-444
20. Olliaro PL, Taylor WR (2004) Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: a review. J Postgrad Med 50: 40-44
21. Taylor WR, Rigal J, Olliaro PL (2003) Drug resistant malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. J Vector Borne Dis 40: 65-72
22. Toovey S, Jamieson A (2004) Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98: 261-267
23. Wernsdorfer WH, Noedl H (2003) Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology. Curr Opin Infect Dis 16: 553-558